Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Diseases: Current Status and Future Perspectives

Primary immunodeficiencies (PID) are disorders that for the most part result from mutations in genes involved in immune host defense and immunoregulation. These conditions are characterized by various combinations of recurrent infections, autoimmunity, lymphoproliferation, inflammatory manifestation...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Frontiers in pediatrics Ročník 7; s. 295
Hlavní autoři: Castagnoli, Riccardo, Delmonte, Ottavia Maria, Calzoni, Enrica, Notarangelo, Luigi Daniele
Médium: Journal Article
Jazyk:angličtina
Vydáno: Switzerland Frontiers Media S.A 08.08.2019
Témata:
graft manipulation
hematopoietic stem cell transplantation
immune dysregulation
Pediatrics
primary immunodeficiency diseases (PID)
severe combined immunodeficiency
transplantation outcomes
graft manipulation
hematopoietic stem cell transplantation
primary immunodeficiency diseases (PID)
precision medicine
severe combined immunodeficiency
conditioning regimens
immune dysregulation
transplantation outcomes
ISSN:2296-2360, 2296-2360
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Primary immunodeficiencies (PID) are disorders that for the most part result from mutations in genes involved in immune host defense and immunoregulation. These conditions are characterized by various combinations of recurrent infections, autoimmunity, lymphoproliferation, inflammatory manifestations, atopy, and malignancy. Most PID are due to genetic defects that are intrinsic to hematopoietic cells. Therefore, replacement of mutant cells by healthy donor hematopoietic stem cells (HSC) represents a rational therapeutic approach. Full or partial ablation of the recipient's marrow with chemotherapy is often used to allow stable engraftment of donor-derived HSCs, and serotherapy may be added to the conditioning regimen to reduce the risks of graft rejection and graft versus host disease (GVHD). Initially, hematopoietic stem cell transplantation (HSCT) was attempted in patients with severe combined immunodeficiency (SCID) as the only available curative treatment. It was a challenging procedure, associated with elevated rates of morbidity and mortality. Overtime, outcome of HSCT for PID has significantly improved due to availability of high-resolution HLA typing, increased use of alternative donors and new stem cell sources, development of less toxic, reduced-intensity conditioning (RIC) regimens, and cellular engineering techniques for graft manipulation. Early identification of infants affected by SCID, prior to infectious complication, through newborn screening (NBS) programs and prompt genetic diagnosis with Next Generation Sequencing (NGS) techniques, have also ameliorated the outcome of HSCT. In addition, HSCT has been applied to treat a broader range of PID, including disorders of immune dysregulation. Yet, the broad spectrum of clinical and immunological phenotypes associated with PID makes it difficult to define a universal transplant regimen. As such, integration of knowledge between immunologists and transplant specialists is necessary for the development of innovative transplant protocols and to monitor their results during follow-up. Despite the improved outcome observed after HSCT, patients with severe forms of PID still face significant challenges of short and long-term transplant-related complications. To address this issue, novel HSCT strategies are being implemented aiming to improve both survival and long-term quality of life. This article will discuss the current status and latest developments in HSCT for PID, and present data regarding approach and outcome of HSCT in recently described PID, including disorders associated with immune dysregulation.
AbstractList Primary immunodeficiencies (PID) are disorders that for the most part result from mutations in genes involved in immune host defense and immunoregulation. These conditions are characterized by various combinations of recurrent infections, autoimmunity, lymphoproliferation, inflammatory manifestations, atopy, and malignancy. Most PID are due to genetic defects that are intrinsic to hematopoietic cells. Therefore, replacement of mutant cells by healthy donor hematopoietic stem cells (HSC) represents a rational therapeutic approach. Full or partial ablation of the recipient's marrow with chemotherapy is often used to allow stable engraftment of donor-derived HSCs, and serotherapy may be added to the conditioning regimen to reduce the risks of graft rejection and graft versus host disease (GVHD). Initially, hematopoietic stem cell transplantation (HSCT) was attempted in patients with severe combined immunodeficiency (SCID) as the only available curative treatment. It was a challenging procedure, associated with elevated rates of morbidity and mortality. Overtime, outcome of HSCT for PID has significantly improved due to availability of high-resolution HLA typing, increased use of alternative donors and new stem cell sources, development of less toxic, reduced-intensity conditioning (RIC) regimens, and cellular engineering techniques for graft manipulation. Early identification of infants affected by SCID, prior to infectious complication, through newborn screening (NBS) programs and prompt genetic diagnosis with Next Generation Sequencing (NGS) techniques, have also ameliorated the outcome of HSCT. In addition, HSCT has been applied to treat a broader range of PID, including disorders of immune dysregulation. Yet, the broad spectrum of clinical and immunological phenotypes associated with PID makes it difficult to define a universal transplant regimen. As such, integration of knowledge between immunologists and transplant specialists is necessary for the development of innovative transplant protocols and to monitor their results during follow-up. Despite the improved outcome observed after HSCT, patients with severe forms of PID still face significant challenges of short and long-term transplant-related complications. To address this issue, novel HSCT strategies are being implemented aiming to improve both survival and long-term quality of life. This article will discuss the current status and latest developments in HSCT for PID, and present data regarding approach and outcome of HSCT in recently described PID, including disorders associated with immune dysregulation.Primary immunodeficiencies (PID) are disorders that for the most part result from mutations in genes involved in immune host defense and immunoregulation. These conditions are characterized by various combinations of recurrent infections, autoimmunity, lymphoproliferation, inflammatory manifestations, atopy, and malignancy. Most PID are due to genetic defects that are intrinsic to hematopoietic cells. Therefore, replacement of mutant cells by healthy donor hematopoietic stem cells (HSC) represents a rational therapeutic approach. Full or partial ablation of the recipient's marrow with chemotherapy is often used to allow stable engraftment of donor-derived HSCs, and serotherapy may be added to the conditioning regimen to reduce the risks of graft rejection and graft versus host disease (GVHD). Initially, hematopoietic stem cell transplantation (HSCT) was attempted in patients with severe combined immunodeficiency (SCID) as the only available curative treatment. It was a challenging procedure, associated with elevated rates of morbidity and mortality. Overtime, outcome of HSCT for PID has significantly improved due to availability of high-resolution HLA typing, increased use of alternative donors and new stem cell sources, development of less toxic, reduced-intensity conditioning (RIC) regimens, and cellular engineering techniques for graft manipulation. Early identification of infants affected by SCID, prior to infectious complication, through newborn screening (NBS) programs and prompt genetic diagnosis with Next Generation Sequencing (NGS) techniques, have also ameliorated the outcome of HSCT. In addition, HSCT has been applied to treat a broader range of PID, including disorders of immune dysregulation. Yet, the broad spectrum of clinical and immunological phenotypes associated with PID makes it difficult to define a universal transplant regimen. As such, integration of knowledge between immunologists and transplant specialists is necessary for the development of innovative transplant protocols and to monitor their results during follow-up. Despite the improved outcome observed after HSCT, patients with severe forms of PID still face significant challenges of short and long-term transplant-related complications. To address this issue, novel HSCT strategies are being implemented aiming to improve both survival and long-term quality of life. This article will discuss the current status and latest developments in HSCT for PID, and present data regarding approach and outcome of HSCT in recently described PID, including disorders associated with immune dysregulation.
Primary immunodeficiencies (PID) are disorders that for the most part result from mutations in genes involved in immune host defense and immunoregulation. These conditions are characterized by various combinations of recurrent infections, autoimmunity, lymphoproliferation, inflammatory manifestations, atopy, and malignancy. Most PID are due to genetic defects that are intrinsic to hematopoietic cells. Therefore, replacement of mutant cells by healthy donor hematopoietic stem cells (HSC) represents a rational therapeutic approach. Full or partial ablation of the recipient's marrow with chemotherapy is often used to allow stable engraftment of donor-derived HSCs, and serotherapy may be added to the conditioning regimen to reduce the risks of graft rejection and graft versus host disease (GVHD). Initially, hematopoietic stem cell transplantation (HSCT) was attempted in patients with severe combined immunodeficiency (SCID) as the only available curative treatment. It was a challenging procedure, associated with elevated rates of morbidity and mortality. Overtime, outcome of HSCT for PID has significantly improved due to availability of high-resolution HLA typing, increased use of alternative donors and new stem cell sources, development of less toxic, reduced-intensity conditioning (RIC) regimens, and cellular engineering techniques for graft manipulation. Early identification of infants affected by SCID, prior to infectious complication, through newborn screening (NBS) programs and prompt genetic diagnosis with Next Generation Sequencing (NGS) techniques, have also ameliorated the outcome of HSCT. In addition, HSCT has been applied to treat a broader range of PID, including disorders of immune dysregulation. Yet, the broad spectrum of clinical and immunological phenotypes associated with PID makes it difficult to define a universal transplant regimen. As such, integration of knowledge between immunologists and transplant specialists is necessary for the development of innovative transplant protocols and to monitor their results during follow-up. Despite the improved outcome observed after HSCT, patients with severe forms of PID still face significant challenges of short and long-term transplant-related complications. To address this issue, novel HSCT strategies are being implemented aiming to improve both survival and long-term quality of life. This article will discuss the current status and latest developments in HSCT for PID, and present data regarding approach and outcome of HSCT in recently described PID, including disorders associated with immune dysregulation.
Author Castagnoli, Riccardo
Delmonte, Ottavia Maria
Calzoni, Enrica
Notarangelo, Luigi Daniele
AuthorAffiliation 3 Department of Molecular and Translational Medicine, A. Nocivelli Institute for Molecular Medicine, University of Brescia , Brescia , Italy
2 Department of Pediatrics, Foundation IRCCS Policlinico San Matteo, University of Pavia , Pavia , Italy
1 Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, MD , United States
AuthorAffiliation_xml – name: 1 Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, MD , United States
– name: 2 Department of Pediatrics, Foundation IRCCS Policlinico San Matteo, University of Pavia , Pavia , Italy
– name: 3 Department of Molecular and Translational Medicine, A. Nocivelli Institute for Molecular Medicine, University of Brescia , Brescia , Italy
Author_xml – sequence: 1
  givenname: Riccardo
  surname: Castagnoli
  fullname: Castagnoli, Riccardo
– sequence: 2
  givenname: Ottavia Maria
  surname: Delmonte
  fullname: Delmonte, Ottavia Maria
– sequence: 3
  givenname: Enrica
  surname: Calzoni
  fullname: Calzoni, Enrica
– sequence: 4
  givenname: Luigi Daniele
  surname: Notarangelo
  fullname: Notarangelo, Luigi Daniele
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31440487$$D View this record in MEDLINE/PubMed
BookMark eNp1ks9vFCEUxyemxtbaszczRy-75dcw4MHEbK3dpIlNrGfCwKPSzMAITJP-97Ld1rQmcgAC7_t5PN73bXMQYoCmeY_RmlIhT90Mdk0QlmuEiOxeNUeESL4ilKODZ_vD5iTnW1SH7FGHuzfNIcWMISb6o6ZcwKRLnKOH4k37o8DUbmAc2-ukQ55HHYouPobWh_Yq-Umn-3Y7TUuIFpw3HoK5b898Bp0hf2o3S0oQSuXosuRWB9ueL2VJ0F5ByjOY4u8gv2teOz1mOHlcj5uf51-vNxery-_ftpsvlyvTka6sBHeDRhQ7C8AQxz0XkoODwTCChKAwIMeMoxZLzYUxqBsEY67vhbCWdECPm-2ea6O-VfP--Spqrx4OYrpROtWyR1DGYoI5IO4kZtw6qaVkBEBgJgbjXGV93rPmZZjAmlpl0uML6Mub4H-pm3inOJesp10FfHwEpPh7gVzU5LOpX60DxCUrQimXgtephn54nutvkqe21YBuH2BSzDmBU8bv-1RT-1FhpHYOUTuHqJ1D1INDqu70H90T-n-KPzeBwXo
CitedBy_id crossref_primary_10_3390_pharmaceutics15030969
crossref_primary_10_1111_pai_13701
crossref_primary_10_26815_acn_2022_00241
crossref_primary_10_1093_ecco_jcc_jjz206
crossref_primary_10_7759_cureus_90448
crossref_primary_10_1007_s10875_021_01182_5
crossref_primary_10_1038_s41375_025_02750_z
crossref_primary_10_3390_jcm10204729
crossref_primary_10_1097_TP_0000000000005377
crossref_primary_10_1016_j_tjog_2021_05_004
crossref_primary_10_3390_metabo15070489
crossref_primary_10_1002_ajmg_a_62021
crossref_primary_10_1111_apt_16837
crossref_primary_10_3390_pharmaceutics12060549
crossref_primary_10_3390_ijerph20115993
crossref_primary_10_1097_BOR_0000000000000688
crossref_primary_10_3389_fimmu_2020_01065
crossref_primary_10_1080_1744666X_2021_1945443
crossref_primary_10_3389_fimmu_2021_671755
crossref_primary_10_3389_fimmu_2022_1018685
crossref_primary_10_1111_cei_13620
crossref_primary_10_1002_pbc_30429
crossref_primary_10_1038_s41409_022_01704_8
crossref_primary_10_1007_s10875_020_00811_9
crossref_primary_10_1016_j_jaci_2019_12_004
crossref_primary_10_1111_imr_13305
crossref_primary_10_1016_j_jtct_2023_06_006
crossref_primary_10_1111_petr_13699
crossref_primary_10_1016_j_jaip_2021_10_033
crossref_primary_10_3390_ijms22031416
crossref_primary_10_1016_j_omtm_2024_101359
crossref_primary_10_1111_tid_14124
crossref_primary_10_1097_MOP_0000000000001092
crossref_primary_10_3389_fcimb_2023_1223824
crossref_primary_10_1186_s13223_024_00938_z
crossref_primary_10_3389_fimmu_2020_607926
crossref_primary_10_1093_burnst_tkae053
crossref_primary_10_3389_fimmu_2020_01954
crossref_primary_10_3389_fimmu_2020_01317
crossref_primary_10_3389_fped_2022_883173
crossref_primary_10_1016_j_socscimed_2024_117303
crossref_primary_10_1111_pai_13847
crossref_primary_10_1007_s10875_023_01476_w
crossref_primary_10_3389_fimmu_2022_960348
crossref_primary_10_1016_j_jaci_2025_04_032
crossref_primary_10_3389_fimmu_2024_1371124
crossref_primary_10_1016_S1773_035X_23_00024_2
crossref_primary_10_1002_ajh_26903
crossref_primary_10_1111_petr_14239
crossref_primary_10_1016_j_gene_2020_145246
crossref_primary_10_3389_fmed_2020_569291
crossref_primary_10_5507_bp_2023_028
crossref_primary_10_1007_s10875_023_01535_2
crossref_primary_10_1007_s10875_021_01155_8
crossref_primary_10_3390_cells11030557
crossref_primary_10_3389_fimmu_2023_1229674
crossref_primary_10_1016_j_yexcr_2023_113599
crossref_primary_10_3390_cells11213353
crossref_primary_10_1007_s10875_023_01483_x
crossref_primary_10_1038_s41568_024_00723_5
crossref_primary_10_3389_fimmu_2022_982772
crossref_primary_10_1016_j_jtct_2022_12_007
crossref_primary_10_1007_s12016_021_08916_8
crossref_primary_10_3389_fimmu_2021_790455
crossref_primary_10_7759_cureus_44865
crossref_primary_10_1038_s41409_022_01739_x
crossref_primary_10_1007_s00430_022_00759_0
crossref_primary_10_1038_s41576_020_00298_5
crossref_primary_10_3389_fimmu_2023_1111777
crossref_primary_10_1007_s10875_024_01753_2
crossref_primary_10_1097_JS9_0000000000002111
crossref_primary_10_1016_j_jaip_2020_11_055
crossref_primary_10_1016_j_jped_2020_10_005
crossref_primary_10_5500_wjt_v15_i2_100065
crossref_primary_10_3389_fimmu_2020_01411
crossref_primary_10_12688_f1000research_21553_1
crossref_primary_10_1016_j_drudis_2022_01_002
crossref_primary_10_3390_ma14030569
crossref_primary_10_1007_s10875_020_00923_2
crossref_primary_10_1002_stem_3327
crossref_primary_10_1038_s41409_022_01883_4
crossref_primary_10_1111_pai_13231
crossref_primary_10_3389_fimmu_2020_581119
crossref_primary_10_1146_annurev_immunol_093019_124513
crossref_primary_10_1038_s41409_021_01310_0
crossref_primary_10_3389_fgeed_2023_1114996
crossref_primary_10_2147_JBM_S528827
crossref_primary_10_1016_j_clim_2022_109067
crossref_primary_10_1111_ejh_13536
crossref_primary_10_3389_fimmu_2021_644687
crossref_primary_10_3390_ijms25052977
crossref_primary_10_1016_j_jped_2020_10_014
crossref_primary_10_1182_blood_2022018568
crossref_primary_10_1038_s41390_021_01445_2
crossref_primary_10_3390_biom10081112
crossref_primary_10_1007_s10875_023_01505_8
crossref_primary_10_1007_s10875_023_01465_z
crossref_primary_10_1111_jpc_15186
crossref_primary_10_1016_j_waojou_2021_100513
crossref_primary_10_1186_s12887_022_03726_z
crossref_primary_10_1016_j_jtct_2021_08_019
crossref_primary_10_1007_s10875_024_01853_z
crossref_primary_10_1111_pai_13365
crossref_primary_10_1089_crispr_2020_0111
crossref_primary_10_36290_ped_2021_005
crossref_primary_10_1111_sji_13431
crossref_primary_10_1016_j_ymthe_2020_11_020
crossref_primary_10_3389_fimmu_2025_1597635
crossref_primary_10_1182_blood_2021014654
crossref_primary_10_3390_pathogens12040518
crossref_primary_10_1111_bjh_17070
crossref_primary_10_3389_fimmu_2023_1155883
crossref_primary_10_1097_ACI_0000000000001059
crossref_primary_10_1007_s10875_022_01381_8
crossref_primary_10_1016_j_jaci_2020_08_010
crossref_primary_10_1016_j_jaci_2025_01_029
crossref_primary_10_1016_j_mayocp_2022_08_021
crossref_primary_10_3389_fgeed_2021_618406
crossref_primary_10_1038_s41587_024_02470_2
crossref_primary_10_3389_fimmu_2020_01988
crossref_primary_10_24287_1726_1708_2020_19_4_165_177
crossref_primary_10_7759_cureus_83304
crossref_primary_10_1007_s12185_024_03898_7
crossref_primary_10_1016_j_biopha_2022_114131
crossref_primary_10_1038_s41423_020_00520_8
crossref_primary_10_1002_pbc_28091
crossref_primary_10_1038_s41591_022_01934_9
crossref_primary_10_2500_aap_2024_45_240069
crossref_primary_10_1007_s00431_022_04614_5
crossref_primary_10_1038_s41409_022_01589_7
crossref_primary_10_3390_vaccines13040397
crossref_primary_10_3390_idr17030048
Cites_doi 10.1016/S0002-9343(98)00200-9
10.1016/j.jaci.2016.06.021
10.1182/blood-2014-09-602763
10.1016/j.clim.2012.10.003
10.1016/S0140-6736(68)92672-X
10.1016/j.bbmt.2015.07.008
10.1016/j.jaci.2017.04.035
10.1182/blood-2006-05-025072
10.1182/blood-2009-09-239087
10.1542/peds.113.2.e122
10.1172/JCI62949
10.3389/fimmu.2018.02554
10.1097/00005792-200005000-00004
10.1007/s10875-015-0231-8
10.1038/sj.bmt.1702446
10.1002/pbc.26048
10.1038/nm.3746
10.1016/j.jaci.2013.05.031
10.1111/petr.13015
10.1038/sj.bmt.1705520
10.1056/NEJMoa1506002
10.1007/s10875-008-9196-1
10.1182/blood-2017-09-807487
10.1002/eji.200939385
10.1016/j.iac.2009.10.004
10.1007/s10875-007-9160-5
10.1016/j.clim.2011.07.005
10.1016/j.iac.2010.01.001
10.1182/blood-2010-08-301101
10.1016/j.jaci.2010.06.015
10.1007/s10875-015-0167-z
10.1080/1744666X.2018.1424627
10.1016/j.jaci.2010.07.034
10.1056/NEJMoa0905506
10.1016/S0022-3476(05)82002-5
10.1084/jem.20151110
10.1016/j.jaci.2010.05.005
10.1016/j.jaci.2018.07.020
10.1182/blood-2012-06-432500
10.1016/j.jaci.2019.02.003
10.1172/JCI80477
10.1016/j.ajhg.2012.04.015
10.1182/blood-2014-03-563817
10.1016/j.jaci.2014.10.048
10.1016/j.bbmt.2019.03.009
10.1111/bjd.14679
10.1007/s10875-017-0464-9
10.1084/jem.20110896
10.1038/bmt.2016.64
10.1056/NEJMoa1100102
10.1007/s00431-008-0718-x
10.1182/blood-2009-02-206359
10.1016/j.jaci.2009.10.038
10.1016/j.bbmt.2014.06.003
10.1126/science.aaa1663
10.1111/j.1399-3046.2010.01292.x
10.1056/NEJM200103223441203
10.1007/s10875-018-0537-4
10.1016/j.jaci.2016.02.022
10.4049/jimmunol.1700460
10.1002/pbc.25756
10.1016/j.jaci.2015.07.047
10.1016/j.jaci.2018.08.024
10.1016/j.bbmt.2017.03.016
10.1182/blood-2018-02-835561
10.3389/fimmu.2018.03146
10.1016/j.jaci.2011.03.025
10.1016/S0952-7915(97)80078-7
10.1056/NEJMoa031178
10.1038/ncomms14816
10.1126/science.8202712
10.3389/fimmu.2018.00369
10.1111/petr.12405
10.1016/j.jaci.2013.01.042
10.1016/j.jaci.2017.02.036
10.1016/j.jaci.2016.11.022
10.1038/bmt.2012.140
10.1016/j.bbmt.2016.02.001
10.1016/j.jaci.2018.02.055
10.1182/blood.V99.6.2268
10.1182/blood-2016-11-745638
10.1172/JCI22588
10.1038/ni.1662
10.1016/j.jaci.2016.05.036
10.1016/j.jaci.2017.10.041
10.1111/ped.12819
10.1016/j.jaci.2016.09.040
10.1038/nri.2016.93
10.1016/j.ajhg.2014.05.007
10.1056/NEJMoa053750
10.1016/j.jaci.2016.01.045
10.1146/annurev-immunol-032712-095927
10.1016/j.jaci.2015.02.020
10.1007/s10875-017-0453-z
10.1016/j.jaci.2016.07.039
10.1126/science.8202713
10.1016/j.jaci.2016.08.036
10.1007/BF02002714
10.1182/blood-2010-06-284935
10.1007/s00251-017-0971-0
10.1007/s10875-017-0465-8
10.1007/s10875-016-0278-1
10.1016/S0140-6736(68)92673-1
10.1182/blood-2010-10-312082
10.1084/jem.20150888
10.1182/blood-2014-03-564930
10.1126/science.156.3781.1506
10.1182/blood-2013-01-478735
10.1155/2010/781523
10.1016/j.jaci.2013.08.035
10.1016/j.bbmt.2015.01.022
10.1182/blood-2018-07-863431
10.1016/j.jaci.2015.09.030
10.1038/sj.bmt.1705016
10.1182/blood-2017-10-809822
10.1182/blood-2011-09-378158
10.1080/1744666X.2018.1459189
10.1016/j.clim.2013.07.004
10.4049/jimmunol.158.2.977
10.1172/JCI37901
10.1016/j.jaci.2013.02.038
10.1016/0092-8674(94)90368-9
10.1038/bmt.2017.74
10.1182/blood-2013-01-476432
10.1056/NEJM199902183400703
10.1016/j.jaci.2014.08.019
10.1016/S0140-6736(13)62069-3
10.3109/08880018.2012.714844
10.1016/j.jaip.2018.10.035
10.1172/JCI85774
10.1073/pnas.221456898
10.1111/j.1399-3046.2008.00957.x
10.1182/blood-2015-11-679902
10.1016/j.jaci.2016.01.053
10.1016/j.jaip.2019.02.038
10.1093/cid/civ1220
10.1182/blood-2017-04-777383
10.1097/00005792-200005000-00003
10.1016/j.jaci.2018.10.026
10.1016/j.jaci.2018.04.032
10.1016/j.jaci.2011.05.031
10.1056/NEJMra1609337
10.1016/j.jaci.2012.09.020
10.1016/j.jaci.2019.01.030
10.1056/NEJMoa1413462
10.1016/j.jaci.2015.12.1311
10.1016/j.jaci.2010.05.021
10.3324/haematol.2010.033910
10.1016/j.jaci.2012.07.029
10.1126/science.1243292
10.1182/blood-2016-10-745455
10.1038/ng.3040
10.1016/j.bbmt.2007.01.076
10.1016/j.jaci.2017.03.049
10.1016/j.jaci.2017.10.051
10.3389/fimmu.2017.00052
10.1016/j.jaci.2016.03.022
10.1056/NEJMoa1401177
10.3389/fimmu.2018.00666
10.1182/blood-2016-11-748616
10.1182/blood-2010-11-319376
10.1056/NEJM200106073442304
10.1056/NEJM199508173330705
10.1182/blood-2011-06-362533
10.1016/S0022-3476(03)00274-9
10.1038/3877
10.1016/j.jaip.2016.06.028
10.1126/science.1255904
10.1038/ng0495-414
10.1016/j.jaci.2017.07.008
10.3389/fimmu.2018.00338
10.1038/sj.bmt.1705713
10.1182/blood-2003-06-2014
10.1016/j.jaci.2016.06.020
10.1159/000333472
10.1016/j.jaci.2018.12.1010
10.1016/j.jaci.2017.02.029
10.1182/blood-2011-12-396879
10.1016/j.jaci.2015.09.025
10.1182/blood-2018-03-840702
10.1007/s10875-016-0289-y
10.1016/j.clim.2007.09.008
10.1007/s10875-016-0316-z
10.1016/j.jaci.2016.09.061
10.1038/nri.2016.28
10.1038/sj.bmt.1703800
10.3389/fimmu.2018.02197
10.1182/blood-2017-08-801191
10.1038/s41409-018-0219-0
10.1016/j.clim.2017.01.012
10.1016/j.jaci.2018.06.042
ContentType Journal Article
Copyright Copyright © 2019 Castagnoli, Delmonte, Calzoni and Notarangelo. 2019 Castagnoli, Delmonte, Calzoni and Notarangelo
Copyright_xml – notice: Copyright © 2019 Castagnoli, Delmonte, Calzoni and Notarangelo. 2019 Castagnoli, Delmonte, Calzoni and Notarangelo
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.3389/fped.2019.00295
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals (ODIN)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2296-2360
ExternalDocumentID oai_doaj_org_article_cd1216e06f9146df9a9942ee8148bcff
PMC6694735
31440487
10_3389_fped_2019_00295
Genre Journal Article
Review
GroupedDBID 53G
5VS
9T4
AAFWJ
AAYXX
ACGFO
ACGFS
ADBBV
ADRAZ
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
OK1
PGMZT
RNS
RPM
ACXDI
EMOBN
IAO
IEA
IHR
IHW
IPNFZ
NPM
RIG
7X8
5PM
ID FETCH-LOGICAL-c525t-86fba031fdee406176896efebc420883eb0f4cf3d19a68cc05b844f7788dd25e3
IEDL.DBID DOA
ISICitedReferencesCount 139
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000479229400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2296-2360
IngestDate Fri Oct 03 12:23:58 EDT 2025
Thu Aug 21 18:24:21 EDT 2025
Wed Oct 01 14:32:33 EDT 2025
Thu Jan 02 23:00:49 EST 2025
Sat Nov 29 02:51:31 EST 2025
Tue Nov 18 22:23:15 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords graft manipulation
hematopoietic stem cell transplantation
primary immunodeficiency diseases (PID)
precision medicine
severe combined immunodeficiency
conditioning regimens
immune dysregulation
transplantation outcomes
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c525t-86fba031fdee406176896efebc420883eb0f4cf3d19a68cc05b844f7788dd25e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Edited by: Kaan Boztug, CeMM Research Center for Molecular Medicine (OAW), Austria
Reviewed by: Daniele Zama, Sant'Orsola-Malpighi Polyclinic, Italy; Aleš Janda, Freiburg University Medical Center, Germany
This article was submitted to Pediatric Immunology, a section of the journal Frontiers in Pediatrics
OpenAccessLink https://doaj.org/article/cd1216e06f9146df9a9942ee8148bcff
PMID 31440487
PQID 2336986369
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_cd1216e06f9146df9a9942ee8148bcff
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6694735
proquest_miscellaneous_2336986369
pubmed_primary_31440487
crossref_citationtrail_10_3389_fped_2019_00295
crossref_primary_10_3389_fped_2019_00295
PublicationCentury 2000
PublicationDate 2019-08-08
PublicationDateYYYYMMDD 2019-08-08
PublicationDate_xml – month: 08
  year: 2019
  text: 2019-08-08
  day: 08
PublicationDecade 2010
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in pediatrics
PublicationTitleAlternate Front Pediatr
PublicationYear 2019
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Al-Herz (B9) 2019; 9
Delmonte (B35) 2018; 38
Burroughs (B159) 2010; 126
Goussetis (B135) 2010; 126
Elfeky (B14) 2019; 144
Notarangelo (B74) 2013; 31
Dvorak (B32) 2017; 52
Yong (B149) 2008; 28
Weinacht (B152) 2017; 139
Bach (B4) 1968; 292
Liu (B88) 2017; 69
Booth (B189) 2011; 117
Barlogis (B65) 2011; 128
Sasahara (B115) 2016; 58
Schuetz (B37) 2014; 123
Tsuma (B194) 2015; 19
van de Veerdonk (B169) 2011; 365
Small (B47) 2013; 48
Gennery (B45) 2010; 126
Toubiana (B170) 2016; 127
Martire (B142) 2008; 126
Ozgür (B82) 2008; 12
Al-Herz (B70) 2016; 138
Picard (B86) 2009; 39
Turul (B89) 2009; 168
Mazzolari (B59) 2007; 40
Uygun (B72) 2017; 21
Touzot (B16) 2015; 135
Shiow (B95) 2008; 9
Kucuk (B160) 2016; 137
Gámez-Díaz (B185) 2016; 137
Slatter (B7) 2018; 14
Seidel (B184) 2015; 135
Horwitz (B145) 2001; 344
Crequer (B97) 2012; 122
Elfeky (B114) 2018; 142
Brigida (B125) 2018; 132
Lopez-Herrera (B181) 2012; 90
Naik (B26) 2016; 137
Angulo (B163) 2013; 342
Panchal (B186) 2018; 9
Worth (B193) 2013; 121
Hayward (B50) 1997; 158
Zerbe (B171) 2016; 62
Seidel (B157) 2009; 113
Miggelbrink (B29) 2018; 131
Flanagan (B174) 2014; 46
Marcus (B78) 2011; 128
Zeiser (B25) 2017; 377
Ghosh (B67) 2012; 145
Kuijpers (B121) 2017; 140
Albert (B112) 2010; 115
Engelhardt (B62) 2009; 124
Kröger (B21) 2016; 374
Mäkitie (B126) 2018
Arpaia (B83) 1994; 76
Slatter (B180) 2016; 138
Farmer (B36) 2019; 7
Hassan (B40) 2012; 120
Puel (B31) 1998; 20
Takada (B80) 2016; 51
Ferrari (B57) 2001; 98
Slatter (B19) 2011; 117
Fox (B8) 2018; 131
Tesi (B183) 2016; 36
Rao (B156) 2007; 109
Ferrua (B56) 2019; 143
Pai (B10) 2014; 371
Rieux-Laucat (B77) 2006; 354
Maccari (B150) 2018; 9
Stray-Pedersen (B137) 2014; 95
Barzaghi (B161) 2018; 141
Recher (B28) 2011; 118
Berthet (B127) 1996; 155
Okano (B168) 2019; 143
Dobbs (B73) 2015; 372
Guggenheim (B128) 2006; 38
Cole (B143) 2013; 132
Bakhtiar (B182) 2017; 8
Klein (B23) 2016; 22
Chan (B84) 1994; 264
Kim (B91) 2013; 131
Marin A (B79) 2017; 139
Hoenig (B41) 2017; 129
Somech (B124) 2017; 199
Lo (B153) 2015; 349
Schubert (B178) 2014; 20
Boztug (B66) 2012; 29
Shah (B71) 2017; 23
Sullivan (B111) 1994; 125
Schwinger (B120) 2018; 9
Gennery (B52) 2004; 103
Hsu (B130) 2013; 131
Kohn (B39) 2019; 143
Dvorak (B42) 2010; 30
Elder (B85) 1994; 264
Shah (B22) 2007; 13
Notarangelo (B33) 2016; 16
Marciano (B148) 2018; 141
Lankester (B188) 2005; 36
Lum (B101) 2016; 63
Mansouri (B104) 2012; 158
Huck (B102) 2009; 119
Cuvelier (B92) 2016; 36
Ghosh (B106) 2018; 9
Chan (B87) 2016; 213
Bordon (B129) 2010; 116
Buckley (B27) 1999; 340
Neven (B24) 2019; 25
Basile G de (B76) 2004; 114
Baud (B155) 2001; 344
Bertaina (B11) 2014; 124
Gross (B187) 1996; 17
Keller (B94) 2016; 213
Yanagimachi (B131) 2016; 36
Patel (B136) 2015; 35
Rao (B151) 2017; 130
Coulter (B165) 2017; 139
Moratto (B113) 2011; 118
Freeman (B69) 2016; 4
Dadak (B172) 2017; 178
Abdollahpour (B100) 2012; 119
Walter (B34) 2015; 125
Cuellar-Rodriguez (B68) 2015; 21
Dadi (B75) 2003; 349
Milner (B175) 2015; 125
Nester (B132) 1998; 105
Bousfiha (B2) 2018; 38
Lucas (B162) 2016; 16
Mitsui-Sekinaka (B54) 2015; 136
Haddad (B38) 2018; 132
Segal (B139) 2000; 79
Pfajfer (B119) 2017; 130
Kasow (B158) 2011; 141
Güngör (B18) 2014; 383
Janssen (B116) 2016; 126
Leiding (B173) 2018; 141
Shah (B13) 2018; 141
Rowe (B81) 2018; 131
Slack (B43) 2018; 141
Bach (B3) 1967; 156
Al-Saud (B60) 2018; 54
Volpi (B123) 2019; 143
Blundell (B108) 2010; 29
Rosenzweig (B141) 2008; 28
Fagioli (B90) 2003; 31
Michalovich (B164) 2018; 9
van Kooten (B49) 1997; 9
Schwab (B179) 2018; 142
Flinn (B134) 2016; 36
Notarangelo (B110) 2002; 99
Kutukculer (B58) 2003; 143
Aydin (B63) 2019; 7
Bernth-Jensen (B138) 2016; 137
McDonald (B64) 2010; 126
Moshous (B96) 2013; 131
Notarangelo (B144) 2013; 132
Kuehn (B177) 2014; 345
Gatti (B5) 1968; 292
Kahr (B122) 2017; 8
Thomas (B51) 1995; 333
Marsh (B192) 2013; 121
Picard (B1) 2018; 38
Gennery (B133) 2000; 25
Rao (B20) 2016; 138
Candotti (B107) 2018; 38
de la Morena (B55) 2017; 139
Battersby (B147) 2017; 140
Al-Mousa (B118) 2017; 139
Elfeky (B48) 2018; 141
Forbes (B176) 2018; 142
Nademi (B167) 2017; 139
Jacobsohn (B53) 2004; 113
Stepensky (B103) 2011; 96
Bacchelli (B93) 2017; 139
Cepika (B154) 2018; 142
Marsh (B190) 2014; 20
Laberko (B6) 2018; 14
Chellapandian (B195) 2016; 63
Siepermann (B46) 2011; 15
Morillo-Gutierrez (B146) 2016; 128
Li (B99) 2016; 175
Speckmann (B191) 2013; 149
Elkaim (B166) 2016; 138
Winkelstein (B140) 2000; 79
B15
Lanzi (B117) 2012; 209
B17
Balashov (B12) 2015; 21
Villa (B109) 1995; 9
Hauck (B98) 2012; 130
Abd Hamid (B30) 2017; 129
Picard (B44) 2010; 30
Zhang (B61) 2009; 361
Serwas (B105) 2014; 124
References_xml – volume: 105
  start-page: 162
  year: 1998
  ident: B132
  article-title: Effects of allogeneic peripheral stem cell transplantation in a patient with job syndrome of hyperimmunoglobulinemia E and recurrent infections
  publication-title: Am J Med
  doi: 10.1016/S0002-9343(98)00200-9
– volume: 139
  start-page: 597
  year: 2017
  ident: B165
  article-title: Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: a large patient cohort study
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2016.06.021
– volume: 125
  start-page: 591
  year: 2015
  ident: B175
  article-title: Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations
  publication-title: Blood
  doi: 10.1182/blood-2014-09-602763
– volume: 145
  start-page: 259
  year: 2012
  ident: B67
  article-title: Treosulfan-based conditioning in DOCK8 deficiency: complete lympho-hematopoietic reconstitution with minimal toxicity
  publication-title: Clin Immunol
  doi: 10.1016/j.clim.2012.10.003
– volume: 292
  start-page: 1364
  year: 1968
  ident: B4
  article-title: Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome
  publication-title: Lancet
  doi: 10.1016/S0140-6736(68)92672-X
– volume: 21
  start-page: 1955
  year: 2015
  ident: B12
  article-title: Single-center experience of unrelated and haploidentical stem cell transplantation with TCRαβ and CD19 depletion in children with primary immunodeficiency syndromes
  publication-title: Biol Blood Marrow Transplant
  doi: 10.1016/j.bbmt.2015.07.008
– volume: 141
  start-page: 365
  year: 2018
  ident: B148
  article-title: X-linked carriers of chronic granulomatous disease: Illness, lyonization, and stability
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2017.04.035
– volume: 109
  start-page: 383
  year: 2007
  ident: B156
  article-title: Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning
  publication-title: Blood
  doi: 10.1182/blood-2006-05-025072
– volume: 115
  start-page: 3231
  year: 2010
  ident: B112
  article-title: X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term outcome, and treatment options
  publication-title: Blood
  doi: 10.1182/blood-2009-09-239087
– volume: 113
  start-page: e122
  year: 2004
  ident: B53
  article-title: Nonmyeloablative hematopoietic stem cell transplant for X-linked hyper-immunoglobulin m syndrome with cholangiopathy
  publication-title: Pediatrics
  doi: 10.1542/peds.113.2.e122
– volume: 122
  start-page: 3239
  year: 2012
  ident: B97
  article-title: Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections
  publication-title: J Clin Invest
  doi: 10.1172/JCI62949
– volume: 9
  start-page: 2554
  year: 2018
  ident: B120
  article-title: The phenotype and treatment of WIP deficiency: literature synopsis and review of a patient with pre-transplant serial donor lymphocyte infusions to eliminate CMV
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2018.02554
– volume: 79
  start-page: 170
  year: 2000
  ident: B139
  article-title: Genetic, biochemical, and clinical features of chronic granulomatous disease
  publication-title: Medicine
  doi: 10.1097/00005792-200005000-00004
– volume: 36
  start-page: 107
  year: 2016
  ident: B134
  article-title: Autosomal dominant hyper IgE syndrome–treatment strategies and clinical outcomes
  publication-title: J Clin Immunol
  doi: 10.1007/s10875-015-0231-8
– volume: 25
  start-page: 1303
  year: 2000
  ident: B133
  article-title: Bone marrow transplantation does not correct the hyper IgE syndrome
  publication-title: Bone Marrow Transplant
  doi: 10.1038/sj.bmt.1702446
– volume-title: Cartilage-Hair Hypoplasia – Anauxetic Dysplasia Spectrum Disorders.
  year: 2018
  ident: B126
– volume: 63
  start-page: 1657
  year: 2016
  ident: B101
  article-title: Successful curative therapy with rituximab and allogeneic haematopoietic stem cell transplantation for MALT lymphoma associated with STK4-mutated CD4+ lymphocytopenia
  publication-title: Pediatr Blood Cancer
  doi: 10.1002/pbc.26048
– volume: 20
  start-page: 1410
  year: 2014
  ident: B178
  article-title: Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations
  publication-title: Nat Med
  doi: 10.1038/nm.3746
– volume: 132
  start-page: 1150
  year: 2013
  ident: B143
  article-title: Clinical outcome in children with chronic granulomatous disease managed conservatively or with hematopoietic stem cell transplantation
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2013.05.031
– volume: 21
  start-page: e13015
  year: 2017
  ident: B72
  article-title: Hematopoietic stem cell transplantation from unrelated donors in children with DOCK8 deficiency
  publication-title: Pediatr Transplant
  doi: 10.1111/petr.13015
– ident: B17
– volume: 38
  start-page: 751
  year: 2006
  ident: B128
  article-title: Bone marrow transplantation for cartilage-hair-hypoplasia
  publication-title: Bone Marrow Transplant
  doi: 10.1038/sj.bmt.1705520
– volume: 374
  start-page: 43
  year: 2016
  ident: B21
  article-title: Antilymphocyte globulin for prevention of chronic graft-versus-host disease
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1506002
– volume: 28
  start-page: 581
  year: 2008
  ident: B149
  article-title: Use of Sirolimus in IPEX and IPEX-Like Children
  publication-title: J Clin Immunol
  doi: 10.1007/s10875-008-9196-1
– volume: 131
  start-page: 917
  year: 2018
  ident: B8
  article-title: Successful outcome following allogeneic hematopoietic stem cell transplantation in adults with primary immunodeficiency
  publication-title: Blood
  doi: 10.1182/blood-2017-09-807487
– volume: 39
  start-page: 1966
  year: 2009
  ident: B86
  article-title: Hypomorphic mutation of ZAP70 in human results in a late onset immunodeficiency and no autoimmunity
  publication-title: Eur J Immunol
  doi: 10.1002/eji.200939385
– volume: 30
  start-page: 125
  year: 2010
  ident: B42
  article-title: Radiosensitive severe combined immunodeficiency disease
  publication-title: Immunol Allergy Clin North Am
  doi: 10.1016/j.iac.2009.10.004
– volume: 28
  start-page: 67
  year: 2008
  ident: B141
  article-title: Inflammatory manifestations in chronic granulomatous disease (CGD)
  publication-title: J Clin Immunol
  doi: 10.1007/s10875-007-9160-5
– volume: 141
  start-page: 169
  year: 2011
  ident: B158
  article-title: Therapeutic in vivo selection of thymic-derived natural T regulatory cells following non-myeloablative hematopoietic stem cell transplant for IPEX
  publication-title: Clin Immunol
  doi: 10.1016/j.clim.2011.07.005
– volume: 30
  start-page: 173
  year: 2010
  ident: B44
  article-title: Hematopoietic stem cell transplantation and other management strategies for MHC class II deficiency
  publication-title: Immunol Allergy Clin North Am
  doi: 10.1016/j.iac.2010.01.001
– volume: 116
  start-page: 27
  year: 2010
  ident: B129
  article-title: Clinical and immunologic outcome of patients with cartilage hair hypoplasia after hematopoietic stem cell transplantation
  publication-title: Blood
  doi: 10.1182/blood-2010-08-301101
– volume: 126
  start-page: 602
  year: 2010
  ident: B45
  article-title: Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2010.06.015
– volume: 35
  start-page: 479
  year: 2015
  ident: B136
  article-title: Successful haploidentical donor hematopoietic stem cell transplant and restoration of STAT3 function in an adolescent with autosomal dominant hyper-IgE syndrome
  publication-title: J Clin Immunol
  doi: 10.1007/s10875-015-0167-z
– volume: 14
  start-page: 103
  year: 2018
  ident: B7
  article-title: Hematopoietic cell transplantation in primary immunodeficiency – conventional and emerging indications
  publication-title: Expert Rev Clin Immunol
  doi: 10.1080/1744666X.2018.1424627
– volume: 126
  start-page: 1304
  year: 2010
  ident: B64
  article-title: Successful engraftment of donor marrow after allogeneic hematopoietic cell transplantation in autosomal-recessive hyper-IgE syndrome caused by dedicator of cytokinesis 8 deficiency
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2010.07.034
– volume: 361
  start-page: 2046
  year: 2009
  ident: B61
  article-title: Combined immunodeficiency associated with DOCK8 mutations
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0905506
– volume: 125
  start-page: 876
  year: 1994
  ident: B111
  article-title: A multiinstitutional survey of the Wiskott-Aldrich syndrome
  publication-title: J Pediatr
  doi: 10.1016/S0022-3476(05)82002-5
– volume: 213
  start-page: 1185
  year: 2016
  ident: B94
  article-title: Early onset combined immunodeficiency and autoimmunity in patients with loss-of-function mutation
  publication-title: LAT. J Exp Med
  doi: 10.1084/jem.20151110
– volume: 126
  start-page: 392
  year: 2010
  ident: B135
  article-title: Successful long-term immunologic reconstitution by allogeneic hematopoietic stem cell transplantation cures patients with autosomal dominant hyper-IgE syndrome
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2010.05.005
– volume: 142
  start-page: 1665
  year: 2018
  ident: B176
  article-title: Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2018.07.020
– volume: 121
  start-page: 877
  year: 2013
  ident: B192
  article-title: Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes
  publication-title: Blood
  doi: 10.1182/blood-2012-06-432500
– volume: 143
  start-page: 2296
  year: 2019
  ident: B123
  article-title: A combined immunodeficiency with severe infections, inflammation, and allergy caused by ARPC1B deficiency
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2019.02.003
– volume: 125
  start-page: 4135
  year: 2015
  ident: B34
  article-title: Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency
  publication-title: J Clin Invest
  doi: 10.1172/JCI80477
– volume: 90
  start-page: 986
  year: 2012
  ident: B181
  article-title: Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity
  publication-title: Am J Hum Genet
  doi: 10.1016/j.ajhg.2012.04.015
– volume: 124
  start-page: 822
  year: 2014
  ident: B11
  article-title: HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders
  publication-title: Blood
  doi: 10.1182/blood-2014-03-563817
– volume: 135
  start-page: 1384
  year: 2015
  ident: B184
  article-title: Long-term remission after allogeneic hematopoietic stem cell transplantation in LPS-responsive beige-like anchor (LRBA) deficiency
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2014.10.048
– volume: 25
  start-page: 1363
  year: 2019
  ident: B24
  article-title: Haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide for primary immunodeficiencies and inherited disorders in children
  publication-title: Biol Blood Marrow Transplant
  doi: 10.1016/j.bbmt.2019.03.009
– volume: 175
  start-page: 1204
  year: 2016
  ident: B99
  article-title: Identification of LCK mutation in a family with atypical epidermodysplasia verruciformis with T-cell defects and virus-induced squamous cell carcinoma
  publication-title: Br J Dermatol
  doi: 10.1111/bjd.14679
– volume: 17
  start-page: 741
  year: 1996
  ident: B187
  article-title: Cure of X-linked lymphoproliferative disease (XLP) with allogeneic hematopoietic stem cell transplantation (HSCT): report from the XLP registry
  publication-title: Bone Marrow Transplant
– volume: 38
  start-page: 96
  year: 2018
  ident: B1
  article-title: International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity
  publication-title: J Clin Immunol
  doi: 10.1007/s10875-017-0464-9
– volume: 209
  start-page: 29
  year: 2012
  ident: B117
  article-title: A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP
  publication-title: J Exp Med
  doi: 10.1084/jem.20110896
– volume: 51
  start-page: 1131
  year: 2016
  ident: B80
  article-title: Insufficient immune reconstitution after allogeneic cord blood transplantation without chemotherapy conditioning in patients with SCID caused by CD3δ deficiency
  publication-title: Bone Marrow Transplant
  doi: 10.1038/bmt.2016.64
– volume: 365
  start-page: 54
  year: 2011
  ident: B169
  article-title: STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1100102
– volume: 168
  start-page: 87
  year: 2009
  ident: B89
  article-title: Clinical heterogeneity can hamper the diagnosis of patients with ZAP70 deficiency
  publication-title: Eur J Pediatr
  doi: 10.1007/s00431-008-0718-x
– volume: 113
  start-page: 5689
  year: 2009
  ident: B157
  article-title: Selective engraftment of donor CD4+25high FOXP3-positive T cells in IPEX syndrome after nonmyeloablative hematopoietic stem cell transplantation
  publication-title: Blood
  doi: 10.1182/blood-2009-02-206359
– volume: 124
  start-page: 1289
  year: 2009
  ident: B62
  article-title: Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2009.10.038
– volume: 20
  start-page: 1641
  year: 2014
  ident: B190
  article-title: Reduced-intensity conditioning hematopoietic cell transplantation is an effective treatment for patients with SLAM-associated protein deficiency/X-linked lymphoproliferative disease type 1
  publication-title: Biol Blood Marrow Transplant
  doi: 10.1016/j.bbmt.2014.06.003
– volume: 349
  start-page: 436
  year: 2015
  ident: B153
  article-title: Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy
  publication-title: Science
  doi: 10.1126/science.aaa1663
– volume: 15
  start-page: E80
  year: 2011
  ident: B46
  article-title: MHC class II deficiency cured by unrelated mismatched umbilical cord blood transplantation: case report and review of 68 cases in the literature
  publication-title: Pediatr Transplant
  doi: 10.1111/j.1399-3046.2010.01292.x
– volume: 344
  start-page: 881
  year: 2001
  ident: B145
  article-title: Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft
  publication-title: N Engl J Med
  doi: 10.1056/NEJM200103223441203
– volume: 38
  start-page: 646
  year: 2018
  ident: B35
  article-title: RAG Deficiency: two genes, many diseases
  publication-title: J Clin Immunol
  doi: 10.1007/s10875-018-0537-4
– volume: 138
  start-page: 852
  year: 2016
  ident: B70
  article-title: Hematopoietic stem cell transplantation outcomes for 11 patients with dedicator of cytokinesis 8 deficiency
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2016.02.022
– volume: 199
  start-page: 4036
  year: 2017
  ident: B124
  article-title: Disruption of thrombocyte and T lymphocyte development by a mutation in ARPC1B
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1700460
– volume: 63
  start-page: 355
  year: 2016
  ident: B195
  article-title: Successful allogeneic hematopoietic stem cell transplantation in XIAP deficiency using reduced-intensity conditioning
  publication-title: Pediatr Blood Cancer
  doi: 10.1002/pbc.25756
– volume: 137
  start-page: 321
  year: 2016
  ident: B138
  article-title: Neonatal-onset T(-)B(-)NK(+) severe combined immunodeficiency and neutropenia caused by mutated phosphoglucomutase 3
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2015.07.047
– volume: 143
  start-page: 852
  year: 2019
  ident: B39
  article-title: Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2018.08.024
– volume: 23
  start-page: 980
  year: 2017
  ident: B71
  article-title: Haploidentical related donor hematopoietic stem cell transplantation for dedicator-of-cytokinesis 8 deficiency using post-transplantation cyclophosphamide
  publication-title: Biol Blood Marrow Transplant
  doi: 10.1016/j.bbmt.2017.03.016
– volume: 131
  start-page: 2335
  year: 2018
  ident: B81
  article-title: Patients with CD3G mutations reveal a role for human CD3γ in Treg diversity and suppressive function
  publication-title: Blood
  doi: 10.1182/blood-2018-02-835561
– volume: 9
  start-page: 3146
  year: 2019
  ident: B9
  article-title: Comprehensive genetic results for primary immunodeficiency disorders in a highly consanguineous population
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2018.03146
– volume: 128
  start-page: 420
  year: 2011
  ident: B65
  article-title: Successful allogeneic hematopoietic stem cell transplantation for DOCK8 deficiency
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2011.03.025
– volume: 9
  start-page: 330
  year: 1997
  ident: B49
  article-title: Functions of CD40 on B cells, dendritic cells and other cells
  publication-title: Curr Opin Immunol
  doi: 10.1016/S0952-7915(97)80078-7
– volume: 349
  start-page: 1821
  year: 2003
  ident: B75
  article-title: Effect of CD3delta deficiency on maturation of alpha/beta and gamma/delta T-cell lineages in severe combined immunodeficiency
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa031178
– volume: 8
  start-page: 14816
  year: 2017
  ident: B122
  article-title: Loss of the Arp2/3 complex component ARPC1B causes platelet abnormalities and predisposes to inflammatory disease
  publication-title: Nat Commun
  doi: 10.1038/ncomms14816
– volume: 264
  start-page: 1596
  year: 1994
  ident: B85
  article-title: Human severe combined immunodeficiency due to a defect in ZAP-70, a T cell tyrosine kinase
  publication-title: Science
  doi: 10.1126/science.8202712
– volume: 9
  start-page: 369
  year: 2018
  ident: B164
  article-title: Activated PI3 kinase delta syndrome: from genetics to therapy
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2018.00369
– volume: 19
  start-page: E25
  year: 2015
  ident: B194
  article-title: Successful treatment of idiopathic colitis related to XIAP deficiency with allo-HSCT using reduced-intensity conditioning
  publication-title: Pediatr Transplant
  doi: 10.1111/petr.12405
– volume: 131
  start-page: 1594
  year: 2013
  ident: B96
  article-title: Whole-exome sequencing identifies Coronin-1A deficiency in 3 siblings with immunodeficiency and EBV-associated B-cell lymphoproliferation
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2013.01.042
– volume: 141
  start-page: 322
  year: 2018
  ident: B43
  article-title: Outcome of hematopoietic cell transplantation for DNA double-strand break repair disorders
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2017.02.036
– volume: 139
  start-page: 1629
  year: 2017
  ident: B152
  article-title: Ruxolitinib reverses dysregulated T helper cell responses and controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2016.11.022
– volume: 48
  start-page: 226
  year: 2013
  ident: B47
  article-title: Alternative donor SCT for the treatment of MHC class II deficiency
  publication-title: Bone Marrow Transplant
  doi: 10.1038/bmt.2012.140
– volume: 22
  start-page: 895
  year: 2016
  ident: B23
  article-title: Alternative-donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for nonmalignant disorders
  publication-title: Biol Blood Marrow Transplant
  doi: 10.1016/j.bbmt.2016.02.001
– volume: 142
  start-page: 1932
  year: 2018
  ident: B179
  article-title: Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2018.02.055
– volume: 99
  start-page: 2268
  year: 2002
  ident: B110
  article-title: Missense mutations of the WASP gene cause intermittent X-linked thrombocytopenia
  publication-title: Blood
  doi: 10.1182/blood.V99.6.2268
– volume: 129
  start-page: 2928
  year: 2017
  ident: B41
  article-title: Reticular dysgenesis: international survey on clinical presentation, transplantation, and outcome
  publication-title: Blood
  doi: 10.1182/blood-2016-11-745638
– volume: 114
  start-page: 1512
  year: 2004
  ident: B76
  article-title: Severe combined immunodeficiency caused by deficiency in either the δ or the ε subunit of CD3
  publication-title: J Clin Invest
  doi: 10.1172/JCI22588
– volume: 9
  start-page: 1307
  year: 2008
  ident: B95
  article-title: The actin regulator coronin 1A is mutant in a thymic egress-deficient mouse strain and in a patient with severe combined immunodeficiency
  publication-title: Nat Immunol
  doi: 10.1038/ni.1662
– volume: 139
  start-page: 634
  year: 2017
  ident: B93
  article-title: Mutations in linker for activation of T cells (LAT) lead to a novel form of severe combined immunodeficiency
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2016.05.036
– volume: 141
  start-page: 1036
  year: 2018
  ident: B161
  article-title: Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: an international multicenter retrospective study
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2017.10.041
– volume: 58
  start-page: 4
  year: 2016
  ident: B115
  article-title: WASP-WIP complex in the molecular pathogenesis of Wiskott-Aldrich syndrome
  publication-title: Pediatr Int
  doi: 10.1111/ped.12819
– volume: 139
  start-page: 1046
  year: 2017
  ident: B167
  article-title: Hematopoietic stem cell transplant in patients with activated PI3K delta syndrome
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2016.09.040
– volume: 16
  start-page: 702
  year: 2016
  ident: B162
  article-title: PI3Kδ and primary immunodeficiencies
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri.2016.93
– volume: 95
  start-page: 96
  year: 2014
  ident: B137
  article-title: PGM3 mutations cause a congenital disorder of glycosylation with severe immunodeficiency and skeletal dysplasia
  publication-title: Am J Hum Genet
  doi: 10.1016/j.ajhg.2014.05.007
– volume: 354
  start-page: 1913
  year: 2006
  ident: B77
  article-title: Inherited and somatic CD3zeta mutations in a patient with T-cell deficiency
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa053750
– volume: 138
  start-page: 615
  year: 2016
  ident: B180
  article-title: Hematopoietic stem cell transplantation for CTLA4 deficiency
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2016.01.045
– volume: 31
  start-page: 195
  year: 2013
  ident: B74
  article-title: Functional T cell immunodeficiencies (with T cells present)
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev-immunol-032712-095927
– volume: 136
  start-page: 1018
  year: 2015
  ident: B54
  article-title: Clinical features and hematopoietic stem cell transplantations for CD40 ligand deficiency in Japan
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2015.02.020
– volume: 38
  start-page: 13
  year: 2018
  ident: B107
  article-title: Clinical manifestations and pathophysiological mechanisms of the wiskott-aldrich syndrome
  publication-title: J Clin Immunol
  doi: 10.1007/s10875-017-0453-z
– volume: 139
  start-page: 1282
  year: 2017
  ident: B55
  article-title: Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2016.07.039
– volume: 264
  start-page: 1599
  year: 1994
  ident: B84
  article-title: ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency
  doi: 10.1126/science.8202713
– volume: 139
  start-page: 1039
  year: 2017
  ident: B118
  article-title: Hematopoietic stem cell transplantation corrects WIP deficiency
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2016.08.036
– volume: 155
  start-page: 286
  year: 1996
  ident: B127
  article-title: Bone marrow transplantation in cartilage-hair hypoplasia: correction of the immunodeficiency but not of the chondrodysplasia
  publication-title: Eur J Pediatr
  doi: 10.1007/BF02002714
– volume: 117
  start-page: 53
  year: 2011
  ident: B189
  article-title: X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease
  publication-title: Blood
  doi: 10.1182/blood-2010-06-284935
– volume: 69
  start-page: 199
  year: 2017
  ident: B88
  article-title: Novel compound heterozygous mutations in ZAP70 in a Chinese patient with leaky severe combined immunodeficiency disorder
  publication-title: Immunogenetics
  doi: 10.1007/s00251-017-0971-0
– volume: 38
  start-page: 129
  year: 2018
  ident: B2
  article-title: The 2017 IUIS phenotypic classification for primary immunodeficiencies
  publication-title: J Clin Immunol
  doi: 10.1007/s10875-017-0465-8
– volume: 36
  start-page: 511
  year: 2016
  ident: B131
  article-title: The potential and limits of hematopoietic stem cell transplantation for the treatment of autosomal dominant hyper-IgE syndrome
  publication-title: J Clin Immunol
  doi: 10.1007/s10875-016-0278-1
– volume: 292
  start-page: 1366
  year: 1968
  ident: B5
  article-title: Immunological reconstitution of sex-linked lymphopenic immunological deficiency
  publication-title: Lancet
  doi: 10.1016/S0140-6736(68)92673-1
– volume: 117
  start-page: 4367
  year: 2011
  ident: B19
  article-title: Treosulfan-based conditioning regimens for hematopoietic stem cell transplantation in children with primary immunodeficiency: United Kingdom experience
  publication-title: Blood
  doi: 10.1182/blood-2010-10-312082
– volume: 213
  start-page: 155
  year: 2016
  ident: B87
  article-title: A novel human autoimmune syndrome caused by combined hypomorphic and activating mutations in ZAP-70
  publication-title: J Exp Med
  doi: 10.1084/jem.20150888
– volume: 124
  start-page: 655
  year: 2014
  ident: B105
  article-title: Identification of ITK deficiency as a novel genetic cause of idiopathic CD4+ T-cell lymphopenia
  publication-title: Blood
  doi: 10.1182/blood-2014-03-564930
– volume: 156
  start-page: 1506
  year: 1967
  ident: B3
  article-title: Hu-1: major histocompatibility locus in man
  publication-title: Science
  doi: 10.1126/science.156.3781.1506
– volume: 121
  start-page: 4966
  year: 2013
  ident: B193
  article-title: Successful stem cell transplant with antibody-based conditioning for XIAP deficiency with refractory hemophagocytic lymphohistiocytosis
  publication-title: Blood
  doi: 10.1182/blood-2013-01-478735
– volume: 29
  start-page: 157
  year: 2010
  ident: B108
  article-title: The Wiskott-Aldrich syndrome: The actin cytoskeleton and immune cell function
  publication-title: Dis Markers
  doi: 10.1155/2010/781523
– volume: 132
  start-page: 1164
  year: 2013
  ident: B144
  article-title: The long road to optimal management for chronic granulomatous disease
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2013.08.035
– volume: 21
  start-page: 1037
  year: 2015
  ident: B68
  article-title: Matched related and unrelated donor hematopoietic stem cell transplantation for DOCK8 deficiency
  publication-title: Biol Blood Marrow Transplant
  doi: 10.1016/j.bbmt.2015.01.022
– volume: 132
  start-page: 2362
  year: 2018
  ident: B125
  article-title: T-cell defects in patients with ARPC1B germline mutations account for combined immunodeficiency
  publication-title: Blood
  doi: 10.1182/blood-2018-07-863431
– volume: 137
  start-page: 953
  year: 2016
  ident: B160
  article-title: A challenging undertaking: stem cell transplantation for immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2015.09.030
– volume: 36
  start-page: 99
  year: 2005
  ident: B188
  article-title: Allogeneic stem cell transplantation in X-linked lymphoproliferative disease: two cases in one family and review of the literature
  publication-title: Bone Marrow Transplant
  doi: 10.1038/sj.bmt.1705016
– volume: 131
  start-page: 2967
  year: 2018
  ident: B29
  article-title: B-cell differentiation and IL-21 response in IL2RG/JAK3 SCID patients after hematopoietic stem cell transplantation
  publication-title: Blood
  doi: 10.1182/blood-2017-10-809822
– volume: 119
  start-page: 3450
  year: 2012
  ident: B100
  article-title: The phenotype of human STK4 deficiency
  publication-title: Blood
  doi: 10.1182/blood-2011-09-378158
– volume: 14
  start-page: 297
  year: 2018
  ident: B6
  article-title: Clinical considerations in the hematopoietic stem cell transplant management of primary immunodeficiencies
  publication-title: Expert Rev Clin Immunol
  doi: 10.1080/1744666X.2018.1459189
– volume: 149
  start-page: 133
  year: 2013
  ident: B191
  article-title: X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis
  publication-title: Clin Immunol
  doi: 10.1016/j.clim.2013.07.004
– volume: 158
  start-page: 977
  year: 1997
  ident: B50
  article-title: Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM
  publication-title: J Immunol
  doi: 10.4049/jimmunol.158.2.977
– volume: 119
  start-page: 1350
  year: 2009
  ident: B102
  article-title: Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation
  publication-title: J Clin Invest
  doi: 10.1172/JCI37901
– volume: 131
  start-page: 1586
  year: 2013
  ident: B130
  article-title: Intermediate phenotypes in patients with autosomal dominant hyper-IgE syndrome caused by somatic mosaicism
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2013.02.038
– volume: 76
  start-page: 947
  year: 1994
  ident: B83
  article-title: Defective T cell receptor signaling and CD8+ thymic selection in humans lacking zap-70 kinase
  publication-title: Cell
  doi: 10.1016/0092-8674(94)90368-9
– volume: 52
  start-page: 1036
  year: 2017
  ident: B32
  article-title: Unconditioned unrelated donor bone marrow transplantation for IL7Rα- and Artemis-deficient SCID
  publication-title: Bone Marrow Transplant
  doi: 10.1038/bmt.2017.74
– volume: 123
  start-page: 281
  year: 2014
  ident: B37
  article-title: SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID
  publication-title: Blood
  doi: 10.1182/blood-2013-01-476432
– volume: 340
  start-page: 508
  year: 1999
  ident: B27
  article-title: Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199902183400703
– volume: 135
  start-page: 1303
  year: 2015
  ident: B16
  article-title: CD45RA depletion in HLA-mismatched allogeneic hematopoietic stem cell transplantation for primary combined immunodeficiency: a preliminary study
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2014.08.019
– volume: 383
  start-page: 436
  year: 2014
  ident: B18
  article-title: Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study
  publication-title: Lancet
  doi: 10.1016/S0140-6736(13)62069-3
– volume: 29
  start-page: 585
  year: 2012
  ident: B66
  article-title: Clinical and immunological correction of DOCK8 deficiency by allogeneic hematopoietic stem cell transplantation following a reduced toxicity conditioning regimen
  publication-title: Pediatr Hematol Oncol
  doi: 10.3109/08880018.2012.714844
– volume: 7
  start-page: 848
  year: 2019
  ident: B63
  article-title: Hematopoietic stem cell transplantation as treatment for patients with DOCK8 deficiency
  publication-title: J Allergy Clin Immunol Pract
  doi: 10.1016/j.jaip.2018.10.035
– volume: 126
  start-page: 3837
  year: 2016
  ident: B116
  article-title: A DOCK8-WIP-WASp complex links T cell receptors to the actin cytoskeleton
  publication-title: J Clin Invest
  doi: 10.1172/JCI85774
– volume: 98
  start-page: 12614
  year: 2001
  ident: B57
  article-title: Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.221456898
– volume: 12
  start-page: 910
  year: 2008
  ident: B82
  article-title: Hematopoietic stem cell transplantation in a CD3 gamma-deficient infant with inflammatory bowel disease
  publication-title: Pediatr Transplant
  doi: 10.1111/j.1399-3046.2008.00957.x
– volume: 127
  start-page: 3154
  year: 2016
  ident: B170
  article-title: Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype
  publication-title: Blood
  doi: 10.1182/blood-2015-11-679902
– volume: 138
  start-page: 1152
  year: 2016
  ident: B20
  article-title: Effect of stem cell source on long-term chimerism and event-free survival in children with primary immunodeficiency disorders after fludarabine and melphalan conditioning regimen
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2016.01.053
– ident: B15
– volume: 7
  start-page: 1970
  year: 2019
  ident: B36
  article-title: Outcomes and treatment strategies for autoimmunity and hyperinflammation in patients with RAG deficiency
  publication-title: J Allergy Clin Immunol Pract
  doi: 10.1016/j.jaip.2019.02.038
– volume: 62
  start-page: 986
  year: 2016
  ident: B171
  article-title: Progressive multifocal leukoencephalopathy in primary immune deficiencies: Stat1 gain of function and review of the literature
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/civ1220
– volume: 130
  start-page: 1949
  year: 2017
  ident: B119
  article-title: WIP deficiency severely affects human lymphocyte architecture during migration and synapse assembly
  publication-title: Blood
  doi: 10.1182/blood-2017-04-777383
– volume: 79
  start-page: 155
  year: 2000
  ident: B140
  article-title: Chronic granulomatous disease. Report on a national registry of 368 patients
  publication-title: Medicine
  doi: 10.1097/00005792-200005000-00003
– volume: 142
  start-page: 1679
  year: 2018
  ident: B154
  article-title: Tregopathies: monogenic diseases resulting in regulatory T-cell deficiency
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2018.10.026
– volume: 143
  start-page: 266
  year: 2019
  ident: B168
  article-title: Hematopoietic stem cell transplantation for progressive combined immunodeficiency and lymphoproliferation in patients with activated phosphatidylinositol-3-OH kinase δ syndrome type 1
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2018.04.032
– volume: 128
  start-page: 1050
  year: 2011
  ident: B78
  article-title: Hematopoietic stem cell transplantation for CD3δ deficiency
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2011.05.031
– volume: 377
  start-page: 2167
  year: 2017
  ident: B25
  article-title: Acute graft-versus-host disease — biologic process, prevention, and therapy
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra1609337
– volume: 131
  start-page: 1233
  year: 2013
  ident: B91
  article-title: Emergency treatment for ζ chain-associated protein of 70 kDa (ZAP70) deficiency
  publication-title: J Allergy Clin Immunol.
  doi: 10.1016/j.jaci.2012.09.020
– volume: 144
  start-page: 280
  year: 2019
  ident: B14
  article-title: New graft manipulation strategies improve the outcome of mismatched stem cell transplantation in children with primary immunodeficiencies
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2019.01.030
– volume: 372
  start-page: 2409
  year: 2015
  ident: B73
  article-title: Inherited DOCK2 deficiency in patients with early-onset invasive infections
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1413462
– volume: 137
  start-page: 1498
  year: 2016
  ident: B26
  article-title: Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2015.12.1311
– volume: 126
  start-page: 1000
  year: 2010
  ident: B159
  article-title: Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2010.05.021
– volume: 96
  start-page: 472
  year: 2011
  ident: B103
  article-title: IL-2-inducible T-cell kinase deficiency: clinical presentation and therapeutic approach
  publication-title: Haematologica
  doi: 10.3324/haematol.2010.033910
– volume: 130
  start-page: 1144
  year: 2012
  ident: B98
  article-title: Primary T-cell immunodeficiency with immunodysregulation caused by autosomal recessive LCK deficiency
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2012.07.029
– volume: 342
  start-page: 866
  year: 2013
  ident: B163
  article-title: Phosphoinositide 3-kinase gene mutation predisposes to respiratory infection and airway damage
  publication-title: Science
  doi: 10.1126/science.1243292
– volume: 128
  start-page: 440
  year: 2016
  ident: B146
  article-title: Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience
  publication-title: Blood
  doi: 10.1182/blood-2016-10-745455
– volume: 46
  start-page: 812
  year: 2014
  ident: B174
  article-title: Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease
  publication-title: Nat Genet
  doi: 10.1038/ng.3040
– volume: 13
  start-page: 584
  year: 2007
  ident: B22
  article-title: The effects of campath 1H upon graft-versus-host disease, infection, relapse, and immune reconstitution in recipients of pediatric unrelated transplants
  publication-title: Biol Blood Marrow Transplant
  doi: 10.1016/j.bbmt.2007.01.076
– volume: 141
  start-page: 704
  year: 2018
  ident: B173
  article-title: Hematopoietic stem cell transplantation in patients with gain-of-function signal transducer and activator of transcription 1 mutations
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2017.03.049
– volume: 141
  start-page: 2279
  year: 2018
  ident: B48
  article-title: Umbilical cord blood transplantation without in vivo T-cell depletion for children with MHC class II deficiency
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2017.10.051
– volume: 8
  start-page: 52
  year: 2017
  ident: B182
  article-title: Treatment of infantile inflammatory bowel disease and autoimmunity by allogeneic stem cell transplantation in LPS-responsive beige-like anchor deficiency
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2017.00052
– volume: 138
  start-page: 210
  year: 2016
  ident: B166
  article-title: Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: a cohort study
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2016.03.022
– volume: 371
  start-page: 434
  year: 2014
  ident: B10
  article-title: Transplantation outcomes for severe combined immunodeficiency, 2000–2009
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1401177
– volume: 9
  start-page: 666
  year: 2018
  ident: B186
  article-title: X-Linked lymphoproliferative disease type 1: a clinical and molecular perspective
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2018.00666
– volume: 129
  start-page: 2198
  year: 2017
  ident: B30
  article-title: Long-term outcome of hematopoietic stem cell transplantation for IL2RG/JAK3 SCID: a cohort report
  publication-title: Blood
  doi: 10.1182/blood-2016-11-748616
– volume: 118
  start-page: 1675
  year: 2011
  ident: B113
  article-title: Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study
  publication-title: Blood
  doi: 10.1182/blood-2010-11-319376
– volume: 344
  start-page: 1758
  year: 2001
  ident: B155
  article-title: Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation
  publication-title: N Engl J Med
  doi: 10.1056/NEJM200106073442304
– volume: 333
  start-page: 426
  year: 1995
  ident: B51
  article-title: Brief report: correction of X-linked hyper-IgM syndrome by allogeneic bone marrow transplantation
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199508173330705
– volume: 118
  start-page: 6824
  year: 2011
  ident: B28
  article-title: IL-21 is the primary common γ chain-binding cytokine required for human B-cell differentiation in vivo
  publication-title: Blood
  doi: 10.1182/blood-2011-06-362533
– volume: 143
  start-page: 141
  year: 2003
  ident: B58
  article-title: Outcome of hematopoietic stem cell transplantation in hyper-IgM syndrome caused by CD40 deficiency
  publication-title: J Pediatr
  doi: 10.1016/S0022-3476(03)00274-9
– volume: 20
  start-page: 394
  year: 1998
  ident: B31
  article-title: Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency
  publication-title: Nat Genet
  doi: 10.1038/3877
– volume: 4
  start-page: 1239
  year: 2016
  ident: B69
  article-title: Haploidentical related donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for DOCK8 deficiency
  publication-title: J Allergy Clin Immunol Pract
  doi: 10.1016/j.jaip.2016.06.028
– volume: 345
  start-page: 1623
  year: 2014
  ident: B177
  article-title: Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4
  publication-title: Science
  doi: 10.1126/science.1255904
– volume: 9
  start-page: 414
  year: 1995
  ident: B109
  article-title: X–linked thrombocytopenia and Wiskott–Aldrich syndrome are allelic diseases with mutations in the WASP gene
  publication-title: Nat Genet
  doi: 10.1038/ng0495-414
– volume: 141
  start-page: 1417
  year: 2018
  ident: B13
  article-title: T-cell receptor αβ+ and CD19+ cell–depleted haploidentical and mismatched hematopoietic stem cell transplantation in primary immune deficiency
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2017.07.008
– volume: 9
  start-page: 543
  year: 2018
  ident: B150
  article-title: Disease evolution and response to rapamycin in activated phosphoinositide 3-kinase δ syndrome: the European Society for immunodeficiencies-activated phosphoinositide 3-kinase δ syndrome registry
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2018.00338
– volume: 40
  start-page: 279
  year: 2007
  ident: B59
  article-title: First report of successful stem cell transplantation in a child with CD40 deficiency
  publication-title: Bone Marrow Transplant
  doi: 10.1038/sj.bmt.1705713
– volume: 103
  start-page: 1152
  year: 2004
  ident: B52
  article-title: Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993-2002
  publication-title: Blood
  doi: 10.1182/blood-2003-06-2014
– volume: 139
  start-page: 347
  year: 2017
  ident: B79
  article-title: Primary T-cell immunodeficiency with functional revertant somatic mosaicism in CD247
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2016.06.020
– volume: 158
  start-page: 418
  year: 2012
  ident: B104
  article-title: IL-2-inducible T-cell kinase deficiency with pulmonary manifestations due to disseminated Epstein-Barr virus infection
  publication-title: Int Arch Allergy Immunol
  doi: 10.1159/000333472
– volume: 143
  start-page: 2238
  year: 2019
  ident: B56
  article-title: Hematopoietic stem cell transplantation for CD40 ligand deficiency: results from an EBMT/ESID-IEWP-SCETIDE-PIDTC study
  publication-title: J Allergy Clin Immunol.
  doi: 10.1016/j.jaci.2018.12.1010
– volume: 140
  start-page: 628
  year: 2017
  ident: B147
  article-title: Inflammatory and autoimmune manifestations in X-linked carriers of chronic granulomatous disease in the United Kingdom
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2017.02.029
– volume: 120
  start-page: 3615
  year: 2012
  ident: B40
  article-title: Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency
  publication-title: Blood
  doi: 10.1182/blood-2011-12-396879
– volume: 137
  start-page: 223
  year: 2016
  ident: B185
  article-title: The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2015.09.025
– volume: 132
  start-page: 1737
  year: 2018
  ident: B38
  article-title: SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery
  publication-title: Blood
  doi: 10.1182/blood-2018-03-840702
– volume: 36
  start-page: 480
  year: 2016
  ident: B183
  article-title: Successful hematopoietic stem cell transplantation in a patient with LPS-responsive beige-like anchor (LRBA) gene mutation
  publication-title: J Clin Immunol
  doi: 10.1007/s10875-016-0289-y
– volume: 126
  start-page: 155
  year: 2008
  ident: B142
  article-title: Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic granulomatous disease: an Italian multicenter study
  publication-title: Clin Immunol
  doi: 10.1016/j.clim.2007.09.008
– volume: 36
  start-page: 713
  year: 2016
  ident: B92
  article-title: Long-term outcomes of hematopoietic stem cell transplantation for ZAP70 deficiency
  publication-title: J Clin Immunol
  doi: 10.1007/s10875-016-0316-z
– volume: 140
  start-page: 273
  year: 2017
  ident: B121
  article-title: Combined immunodeficiency with severe inflammation and allergy caused by ARPC1B deficiency
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2016.09.061
– volume: 16
  start-page: 234
  year: 2016
  ident: B33
  article-title: Human RAG mutations: biochemistry and clinical implications
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri.2016.28
– volume: 31
  start-page: 133
  year: 2003
  ident: B90
  article-title: Successful unrelated cord blood transplantation in two children with severe combined immunodeficiency syndrome
  publication-title: Bone Marrow Transplant
  doi: 10.1038/sj.bmt.1703800
– volume: 9
  start-page: 979
  year: 2018
  ident: B106
  article-title: Interleukin-2-inducible T-cell kinase deficiency—new patients, new insight?
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2018.02197
– volume: 130
  start-page: 2307
  year: 2017
  ident: B151
  article-title: Effective "activated PI3Kδ syndrome"-targeted therapy with the PI3Kδ inhibitor leniolisib
  publication-title: Blood
  doi: 10.1182/blood-2017-08-801191
– volume: 54
  start-page: 63
  year: 2018
  ident: B60
  article-title: Haematopoietic stem cell transplant for hyper-IgM syndrome due to CD40 defects: a single-centre experience
  publication-title: Bone Marrow Transplant
  doi: 10.1038/s41409-018-0219-0
– volume: 178
  start-page: 79
  year: 2017
  ident: B172
  article-title: Gain-of-function STAT1 mutations are associated with intracranial aneurysms
  publication-title: Clin Immunol
  doi: 10.1016/j.clim.2017.01.012
– volume: 142
  start-page: 1654
  year: 2018
  ident: B114
  article-title: One hundred percent survival after transplantation of 34 patients with Wiskott-Aldrich syndrome over 20 years
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2018.06.042
SSID ssj0000970515
Score 2.500651
SecondaryResourceType review_article
Snippet Primary immunodeficiencies (PID) are disorders that for the most part result from mutations in genes involved in immune host defense and immunoregulation....
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 295
SubjectTerms graft manipulation
hematopoietic stem cell transplantation
immune dysregulation
Pediatrics
primary immunodeficiency diseases (PID)
severe combined immunodeficiency
transplantation outcomes
Title Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Diseases: Current Status and Future Perspectives
URI https://www.ncbi.nlm.nih.gov/pubmed/31440487
https://www.proquest.com/docview/2336986369
https://pubmed.ncbi.nlm.nih.gov/PMC6694735
https://doaj.org/article/cd1216e06f9146df9a9942ee8148bcff
Volume 7
WOSCitedRecordID wos000479229400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: Directory of Open Access Journals
  customDbUrl:
  eissn: 2296-2360
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000970515
  issn: 2296-2360
  databaseCode: DOA
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2296-2360
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000970515
  issn: 2296-2360
  databaseCode: M~E
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELZghRAXxJvwWBmJA5ewrRM7NjdYtlokdlWJh3qzHGesrVSSapNy5LczY2dLi0BcuPiQ2Ik1D8-MxvMNYy89GDTzus4dGoe8NM7lTro6V0YKtFClk7Fu7evH6vxcLxZmvtPqi-6EJXjgRLgj30zFVMFEBYNK3QTjjCkFgEY_vvYh0OmLXs9OMBXPYFNR85KE5YNRmDkKayBg0CnBUwrqJrFjhiJa_59czN9vSu6Yntkddnv0GfnbtNe77Bq099jNszErfp8NpwS82q27JVUk8k8DfOPHsFrxhFy-cqm8qOXLls8TugT_QHUhXQMEIEHVl_x9ytT0b_gI2cTJD9303LUNn0XkET7_VZnZP2BfZiefj0_zsZtC7qWQQ65VqB2qcGgAyIpjnGEUBKg9Zdh1AfUklD4UzdQ4pb2fyFqXZagwRm4aIaF4yA7aroXHjE-gEJUIEmdAKfETeCwQ0I1WWoJXdcZeXxHX-hFqnDperCyGHMQNS9ywxA0buZGxV9sF60SHv099R9zaTiN47PgAhcaOQmP_JTQZe3HFa4vqRDkS10K36a0oCmW0wiFjjxLvt78qKBGOAV7Gqj2p2NvL_pt2eREhu5Uy1OP5yf_Y_FN2i8gRbyHqZ-xguNzAc3bDfx-W_eUhu14t9GHUBhzPfpz8BAA0Eu0
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hematopoietic+Stem+Cell+Transplantation+in+Primary+Immunodeficiency+Diseases%3A+Current+Status+and+Future+Perspectives&rft.jtitle=Frontiers+in+pediatrics&rft.au=Castagnoli%2C+Riccardo&rft.au=Delmonte%2C+Ottavia+Maria&rft.au=Calzoni%2C+Enrica&rft.au=Notarangelo%2C+Luigi+Daniele&rft.date=2019-08-08&rft.issn=2296-2360&rft.eissn=2296-2360&rft.volume=7&rft.spage=295&rft_id=info:doi/10.3389%2Ffped.2019.00295&rft_id=info%3Apmid%2F31440487&rft.externalDocID=31440487
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2296-2360&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2296-2360&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2296-2360&client=summon